Ipilimumab-heavy immunotherapy combination in metastatic bladder cancer
An immunotherapy combination with a higher dose of ipilimumab produced a 38 percent overall response…
Browsing: PD-1 checkpoint inhibitors
An immunotherapy combination with a higher dose of ipilimumab produced a 38 percent overall response…